(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 1,880.76%63.31K | 3.54%55.43K | -58.72%87.53K | -58.72%87.53K | -69.43%97.84K | -98.97%3.2K | -85.23%53.53K | -43.00%212.04K | -43.00%212.04K | -19.20%320.05K |
-Cash and cash equivalents | 1,880.76%63.31K | 3.54%55.43K | -58.72%87.53K | -58.72%87.53K | -69.43%97.84K | -98.97%3.2K | -85.23%53.53K | -43.00%212.04K | -43.00%212.04K | -19.20%320.05K |
-Accounts receivable | --892 | --840 | -42.09%1.37K | -42.09%1.37K | --758 | --0 | --0 | -16.57%2.36K | -16.57%2.36K | --0 |
Total current assets | -21.54%86.13K | -44.68%85.56K | -56.61%131.1K | -56.61%131.1K | -68.28%125.78K | -71.67%109.77K | -64.20%154.67K | -31.42%302.17K | -31.42%302.17K | -13.98%396.55K |
Non current assets | ||||||||||
-Accumulated depreciation | -93.80%-1.28K | -109.98%-1.12K | -135.82%-948 | -135.82%-948 | -192.25%-792 | -375.54%-661 | ---531 | ---402 | ---402 | ---271 |
Regulatory assets | -88.35%11.9K | -85.98%13.69K | -75.01%21.15K | -75.01%21.15K | -69.65%23.22K | 32.93%102.08K | 40.34%97.64K | 23.29%84.64K | 23.29%84.64K | 21.29%76.5K |
Total assets | -88.25%11K | -85.59%12.85K | -75.96%19.78K | -75.96%19.78K | -81.70%14K | 27.70%93.62K | 28.18%89.18K | 25.00%82.29K | 25.00%82.29K | 21.29%76.5K |
Liabilities | ||||||||||
Current liabilities | ||||||||||
-accounts payable | -65.65%275.95K | -61.88%267.04K | -29.79%259.43K | -29.79%259.43K | 8.93%384.39K | 94.53%803.46K | 26.32%700.53K | 14.27%369.52K | 14.27%369.52K | -12.27%352.89K |
-Total tax payable | 0.70%158.41K | -0.64%157.77K | -13.56%158.01K | -13.56%158.01K | -1.92%157.06K | -1.63%157.31K | -1.04%158.79K | 12.55%182.81K | 12.55%182.81K | -2.22%160.14K |
-Due to related parties current | 25,813.58%726.88K | 1,330.76%631.15K | 126.51%601.93K | 126.51%601.93K | 150.58%500.71K | -98.96%2.81K | --44.11K | 106.62%265.74K | 106.62%265.74K | --199.82K |
-Other payable | 5.36%145.7K | 5.22%143.79K | 5.03%141.93K | 5.03%141.93K | 4.61%140.09K | 3.87%138.29K | 2.89%136.65K | 1.96%135.13K | 1.96%135.13K | 1.08%133.91K |
Current accrued expenses | 0.00%4.9K | 58.80%18.9K | 0.00%18.9K | 0.00%18.9K | 0.00%4.9K | 0.00%4.9K | 60.78%11.9K | -41.29%18.9K | -41.29%18.9K | 0.00%4.9K |
Current liabilities | 24.23%1.01M | 21.22%917.1K | 34.57%880.26K | 34.57%880.26K | 59.61%890.01K | -11.53%811.17K | -3.70%756.55K | -6.23%654.16K | -6.23%654.16K | -8.68%557.62K |
Non current liabilities | ||||||||||
Non current accrued expenses | 5.79%2.06K | 7.16%2.23K | 8.47%2.4K | 8.47%2.4K | -22.26%1.82K | -21.12%1.95K | --2.08K | --2.21K | --2.21K | --2.34K |
Total non current liabilities | 20.41%1.17M | 17.43%1.07M | 24.05%1.04M | 24.05%1.04M | 45.88%1.05M | -10.06%968.48K | -3.25%915.34K | -2.68%836.96K | -2.68%836.96K | -7.31%717.75K |
Shareholders'equity | ||||||||||
Share capital | 0.00%17.22M | 0.00%17.22M | 0.00%17.22M | 0.00%17.22M | 0.00%17.22M | 1.31%17.22M | 1.31%17.22M | 1.31%17.22M | 1.31%17.22M | 1.11%17.22M |
-common stock | 0.00%17.22M | 0.00%17.22M | 0.00%17.22M | 0.00%17.22M | 0.00%17.22M | 1.31%17.22M | 1.31%17.22M | 1.31%17.22M | 1.31%17.22M | 1.11%17.22M |
Additional paid-in capital | 0.00%1.87M | 0.00%1.87M | 0.00%1.87M | 0.00%1.87M | 0.00%1.87M | 0.00%1.87M | 0.00%1.87M | 0.00%1.87M | 0.00%1.87M | 0.00%1.87M |
Retained earnings | -8.27%3.21K | -8.27%3.21K | -41.60%3.21K | -41.60%3.21K | --3.5K | --3.5K | --3.5K | --5.49K | --5.49K | ---- |
Total equity | -6.45%233.89K | -21.07%231.58K | -37.33%275.43K | -37.33%275.43K | -49.76%267.69K | -52.20%250.01K | -48.06%293.4K | -23.32%439.51K | -23.32%439.51K | -10.22%532.8K |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data